Linhui Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Renal Cell Carcinoma

Top Venues

Cell & bioscience

Oxidative medicine and cellular longevity

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Aimin Jiang, Jinxin Li, Ziwei He, Ying Liu, Kun Qiao, Yu Fang, Le Qu, Peng Luo, Anqi Lin, Linhui Wang
Renal cancer: signaling pathways and advances in targeted therapies. MedComm 5 (8) (2024)
Aimin Jiang, Jinxin Li, Ziwei He, Ying Liu, Kun Qiao, Yu Fang, Le Qu, Peng Luo, Anqi Lin, Linhui Wang
Renal cancer: signaling pathways and advances in targeted therapies. MedComm 5 (8) (2024)
Aimin Jiang, Yewei Bao, Anbang Wang, Wenliang Gong, Xinxin Gan, Jie Wang, Yi Bao, Zhenjie Wu, Bing Liu, Juan Lu, Linhui Wang
Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis. Oxidative medicine and cellular longevity 2022 (2022)
Aimin Jiang, Ye Zhou, Wenliang Gong, Xin Pan, Xinxin Gan, Zhenjie Wu, Bing Liu, Le Qu, Linhui Wang
CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative medicine and cellular longevity 2022 (2022)
Aimin Jiang, Peng Luo, Ming Chen, Yu Fang, Bing Liu, Zhenjie Wu, Le Qu, Anbang Wang, Linhui Wang, Chen Cai
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell & bioscience 12 (1) (2022)
Aimin Jiang, Peng Luo, Ming Chen, Yu Fang, Bing Liu, Zhenjie Wu, Le Qu, Anbang Wang, Linhui Wang, Chen Cai
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell & bioscience 12 (1) (2022)
Aimin Jiang, Qingyang Pang, Xinxin Gan, Anbang Wang, Zhenjie Wu, Bing Liu, Peng Luo, Le Qu, Linhui Wang
Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study. Cancer innovation 1 (2) (2022)
Aimin Jiang, Peng Luo, Ming Chen, Yu Fang, Bing Liu, Zhenjie Wu, Le Qu, Anbang Wang, Linhui Wang, Chen Cai
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell & bioscience 12 (1) (2022)
Aimin Jiang, Peng Luo, Ming Chen, Yu Fang, Bing Liu, Zhenjie Wu, Le Qu, Anbang Wang, Linhui Wang, Chen Cai
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell & bioscience 12 (1) (2022)
Anbang Wang, Aimin Jiang, Xinxin Gan, Zheng Wang, Jinming Huang, Kai Dong, Bing Liu, Linhui Wang, Ming Chen
EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR. BioMed research international 2020 (2020)
Anbang Wang, Ming Chen, Hui Wang, Jinming Huang, Yi Bao, Xinxin Gan, Bing Liu, Xin Lu, Linhui Wang
Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis. BioMed research international 2019 (2019)